Haemonetics (HAE) Retained Earnings (2010 - 2026)

Haemonetics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$37.6 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 31.72% year-over-year to -$37.6 million; the TTM figure through Mar 2026 stood at -$37.6 million (up 31.72% YoY), while the FY2026 annual figure was -$37.6 million, up 31.72% from the prior year.
• Retained Earnings was -$37.6 million for Q1 2026 at Haemonetics, down from $381.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $386.6 million in Q2 2024 to a low of -$55.5 million in Q4 2024.
• Historically, Retained Earnings has averaged $135.9 million across 5 years, with a median of $84.1 million in 2022.
• Biggest YoY gain for Retained Earnings was 1226.85% in 2024; the steepest drop was 127.63% in 2024.
• A 5-year view of Retained Earnings shows it stood at $223.8 million in 2022, then slumped by 110.9% to -$24.4 million in 2023, then plunged by 127.63% to -$55.5 million in 2024, then soared by 786.64% to $381.1 million in 2025, then sank by 109.87% to -$37.6 million in 2026.
• The last three Retained Earnings figures came in at -$37.6 million (Q1 2026), $381.1 million (Q4 2025), and $336.3 million (Q3 2025), per Business Quant data.